| Literature DB >> 27649251 |
Michael Floren1, Claudio Migliaresi2, Antonella Motta3.
Abstract
Hydrogels are an attractive class of tunable material platforms that, combined with their structural and functional likeness to biological environments, have a diversity of applications in bioengineering. Several polymers, natural and synthetic, can be used, the material selection being based on the required functional characteristics of the prepared hydrogels. Silk fibroin (SF) is an attractive natural polymer for its excellent processability, biocompatibility, controlled degradation, mechanical properties and tunable formats and a good candidate for the fabrication of hydrogels. Tremendous effort has been made to control the structural and functional characteristic of silk hydrogels, integrating novel biological features with advanced processing techniques, to develop the next generation of functional SF hydrogels. Here, we review the several processing methods developed to prepare advanced SF hydrogel formats, emphasizing a bottom-up approach beginning with critical structural characteristics of silk proteins and their behavior under specific gelation environments. Additionally, the preparation of SF hydrogel blends and other advanced formats will also be discussed. We conclude with a brief description of the attractive utility of SF hydrogels in relevant bioengineering applications.Entities:
Keywords: bioengineering; hydrogel; silk fibroin
Year: 2016 PMID: 27649251 PMCID: PMC5040999 DOI: 10.3390/jfb7030026
Source DB: PubMed Journal: J Funct Biomater ISSN: 2079-4983
Figure 1Frequency of publications related to silk fibroin (SF) (grey) and SF hydrogels (blue) by year. Data obtained by searching for SF and SF hydrogel in the Web of Science.
Figure 2SF hydrogels can be prepared from several methods. Chemical methods: precipitants, pH, HP CO2, chemical crosslinking, chemical modification. Physical methods: temperature, shear force, ultrasound, electric fields.
Figure 3Mechanically-diverse SF hydrogels prepared by different processing techniques. (A) Blending SF with hydroxypropyl methyl cellulose (HPMC) produces robust mechanical prosperities highlighted visually by bending, knotting and compressing. Tensile curves prepared from SF-HPMC blend hydrogels of different concentrations (E). (B–D) Highly elastic hydrogels of SF have been prepared by chemically crosslinking tyrosine residues, dityrosine bonds, within SF via a horseradish peroxidase (HRP) reaction resulting in robust hydrogel networks displaying excellent elasticity and resilience. (D) Strain response of elastic SF hydrogel after compression with 50 g (2) and 100 g (3) brass weights and exhibiting complete recovery after removal (4). (F) Cyclic compression of elastic SF hydrogels reveal excellent recovery below 70% strain; the inset displays complete recovery below 40% strain. (A,D) Reproduced with permission from [64]. (B–D,F) Reproduced with permission from [41].
SF hydrogels have been developed for several tissue engineering applications.
| SF Hydrogel Fabrication | Target Regeneration | Methods | Comments | Ref. |
|---|---|---|---|---|
| SF-gelatin blend prepared by sonication and chemical crosslinking by genipin | Neuronal tissue | Mouse embryonic stem cells (mESCs) were seeded and kept in knockout serum replacement (KSR) for 15 days | Blended gelatin/SFs were able to differentiate ESCs from neural ectodermal to epithelial ectodermal fate compared to tissue culture plastic (TCP) | [ |
| SF hydrogel prepared by CO2 treatment | Vascular Smooth muscle | Culturing of hMSCs within SF hydrogels of variable stiffness and combined with 10 ng/mL TGF-β1 | Upregulation of mature vascular smooth muscle cell phenotype (myosin heavy chain expression) of hMSCs with appropriate SF gel stiffness and growth factor within 72 h | [ |
| VEGF165 and BMP-2 growth factors were encapsulated in 1 mL of 5.0 wt % SF solution and stabilized via sonication (25% amplitude) for 30 s | Bone | Evaluate in situ forming SF hydrogels combined with dual growth factors for rabbit maxillary sinus floor augmentation | VEGF165 and BMP-2 release from injectable SF gels promoted angiogenesis and new bone formation Combined use of VEGF165 and BMP-2 augmented bone regeneration | [ |
| Addition of 1 M citric acid to 2% | Bone | In vitro and in vivo response of injectable SF hydrogels toward osteoblast culture and implantation in critical-size defects of rabbit distal femurs | Significant increase in TGF-β1 secretion was found for SF hydrogel compared to control SF hydrogel accelerated bone remodeling processes in vivo compared to control | [ |
| Sonicated SF hydrogels of various protein concentration | Cartilage | Encapsulated primary calf chondrocytes into SF hydrogels of different protein concentration and compared against a porous silk scaffold control | Proliferation and chondrogenic phenotype maintained by primary chondrocytes encapsulated within SF hydrogels Adjusting silk protein concentration prepared hydrogels mechanical properties similar to cartilage | [ |
| Composite hydrogel combining silk microfibers with sonicated SF hydrogel | Cartilage | Prepared SF-fiber blend hydrogels to mimic fiber morphology found in native cartilage | Equilibrium modulus in the range of cartilage Encapsulation of primary bovine chondrocytes up to 42 days resulted in enhanced cartilage matrix deposition | [ |
| SF-HA blend hydrogel prepared by sonication | Nucleus Pulpous (NP) | Encapsulation of human chondrocytes | Addition of SF improved mechanical properties, while HA preserved swelling Improved degradation of the gels was observe while maintaining NP-like chondrogenic cell growth | [ |
| SF modified with IKVAV peptide and stabilized by sonication | Neuronal tissue | Encapsulation of human neural stem cells | SF hydrogel modified by IKVAV peptide displayed improved cell viability and enhanced neuronal differentiation capability | [ |
Figure 4Applications of SF hydrogels in bioengineering. (A) hMSCs cultured on SF hydrogels of different stiffness with 10 ng/mL TGF-β1 for 72 h for selected vascular SMC markers: calponin (green), myosin heavy chain (MYH11) (orange). Scale bar: 200 μm. (B) hNSCs encapsulated in unmodified and IKVAV-modified SF hydrogels after seven days. Cells were stained with Nestin (green), βIII-tubulin (red); bars = 100 μm. (C) Image of self-assembling SF hydrogels loaded with different amounts of the anticancer drug doxorubicin (red). (D) SF-doxorubicin hydrogel loaded syringe displaying injectability for clinical use. € Influence of SF hydrogel processing and cocoon degumming parameters on the cumulative doxorubicin release into PBS. Statistical analysis was performed by comparison with SF 6 wt % hydrogel; ** p < 0.001, *** p < 0.0001. (A) Reproduced with permission from [15]. (B) Reproduced with permission from [82]. (C–E) Reproduced with permission from [83].